ADVERTISEMENT RETURN TO ISSUEEditorialNEXTAntibody–Drug Conjugates (ADCs): Magic Bullets at Last!John M. Lambert*View Author Information ImmunoGen, Inc., 830 Winter Street, Waltham, Massachusetts 02451, United States*E-mail: [email protected]Cite this: Mol. Pharmaceutics 2015, 12, 6, 1701–1702Publication Date (Web):June 1, 2015Publication History Published online1 June 2015Published inissue 1 June 2015https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.5b00302https://doi.org/10.1021/acs.molpharmaceut.5b00302editorialACS PublicationsCopyright © 2015 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views3751Altmetric-Citations32LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (141 KB) Get e-AlertscloseSUBJECTS:Biopolymers,Cells,Immunology,Peptides and proteins,Toxicity Get e-Alerts
No takes yet. Share an insight, caveat, or question.
John M. Lambert (2015) studied this question.